A clinical study on Siddha trial drug Nilavagai choornam in children having Sirangu.
Phase 2
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2018/09/015605
- Lead Sponsor
- Government Siddha medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Nocturnal itching
Burrows
Papules and papulovesicle
Pustules
Lesion seen in wrist, web of hands,buttocks
Exclusion Criteria
Eczema
Foliculitis
Seborrheic dermatitis
Insect bites
Psoriasis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reducing in clinical symptoms like itching and burrow <br/ ><br>Reduction pustules in affected area <br/ ><br>To evaluate the days of outcome with in the treatment of 28 daysTimepoint: Nil
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: Nil